Oncolytics Biotech Inc. Stock Nasdaq
Equities
CA6823101077
Biotechnology & Medical Research
Sales 2024 * | 1M 733K | Sales 2025 * | 8.12M 5.95M | Capitalization | 110M 80.55M |
---|---|---|---|---|---|
Net income 2024 * | -34M -24.92M | Net income 2025 * | -39M -28.59M | EV / Sales 2024 * | 110 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 13.5 x |
P/E ratio 2024 * |
-3.62
x | P/E ratio 2025 * |
-3.92
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.15% |
Latest transcript on Oncolytics Biotech Inc.
Managers | Title | Age | Since |
---|---|---|---|
Kirk Look
DFI | Director of Finance/CFO | - | 03-03-31 |
Thomas Heineman
CTO | Chief Tech/Sci/R&D Officer | - | 20-07-31 |
Jon Patton
IRC | Investor Relations Contact | - | 20-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Rigby
BRD | Director/Board Member | 56 | 22-09-06 |
Patricia Andrews
BRD | Director/Board Member | 66 | Jan. 08 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 15-06-07 |
1st Jan change | Capi. | |
---|---|---|
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |